Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection

Vaccination caused an underestimation of the cumulative incidence of SARS-CoV-2 infection

Saved in:

Bibliographic Details
Main Author:	Nana Owusu-Boaitey
Format:	Article
Language:	English
Published:	American Society for Microbiology 2025-02-01
Series:	Microbiology Spectrum
Subjects:	SARS-CoV-2 serology vaccines
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.01558-24
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Reply to “Vaccination caused underestimation of cumulative incidence of SARS-CoV-2 infection”
by: Jefferson M. Jones, et al.
Published: (2025-02-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Dose-dependent serological profiling of AdCLD-CoV19-1 vaccine in adults
by: Jung Hyuk Lee, et al.
Published: (2025-01-01)

SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
by: Fabrizio Angius, et al.
Published: (2024-12-01)

Long-term effects of SARS-CoV-2 infection and vaccination in a population-based pediatric cohort
by: Jakob Höppner, et al.
Published: (2025-01-01)

Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
by: Yongjun Sui, et al.
Published: (2025-02-01)

Impact of Metabolic States on SARS-CoV-2 Vaccine Responses in Mouse Models of Obesity and Diabetes
by: Olivia A. Smith, et al.
Published: (2024-12-01)

An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01)

Neurological side effects of SARS-CoV-2 vaccination are common and can be severe
by: Josef Finsterer
Published: (2025-02-01)

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms
by: Mie Suzuki Okutani, et al.
Published: (2025-02-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
by: Chin Shern Lau, et al.
Published: (2024-12-01)

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
by: Linda Mastromanno, et al.
Published: (2025-01-01)

Designing of an innovative conserved multiepitope subunit vaccine targeting SARS-CoV-2 glycoprotein and nucleoprotein through immunoinformatic
by: Temitope Isaac Adelusi, et al.
Published: (2025-01-01)

mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development
by: A. A. Ilyichev, et al.
Published: (2020-12-01)

Vaccination Against SARS-Cov-2 among Patients with Parkinson’s Disease Based on the Results of COVPARK-LT Study
by: R. Kaladytė Lokominienė, et al.
Published: (2024-02-01)

A SARS‐CoV‐2 EG.5 mRNA vaccine induces a broad‐spectrum immune response in mice
by: Hongyu Wang, et al.
Published: (2025-01-01)

Humoral and Cellular Immunity After Vaccination Against SARS-CoV-2 in Relapsing-Remitting Multiple Sclerosis Patients Treated with Interferon Beta and Dimethyl Fumarate
by: Marcin Bazylewicz, et al.
Published: (2025-01-01)

Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice
by: Mariia V. Sergeeva, et al.
Published: (2024-12-01)

COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
by: Ilker Polatoğlu, et al.
Published: (2023-04-01)

Antibody response against an inactive SARS-CoV-2 vaccine among healthcare workers occupied in different divisions
by: Feridun Gürlek, et al.
Published: (2024-06-01)

Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes
by: Ana B. Martínez-Martinez, et al.
Published: (2024-12-01)

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
by: Annalisa Ciabattini, et al.
Published: (2025-03-01)

Placental Infection with Different SARS-CoV-2 Variants Leading to Stillbirth: Report of Two Cases
by: Miriam A. Snow, et al.
Published: (2025-01-01)

Impact of vaccination against SARS-CoV-2 on mortality risk, ICU admission rate, and hospitalization length in hospitalized COVID-19 patients: a cross-sectional study
by: Behnam Maleki, et al.
Published: (2025-01-01)

Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA
by: Vipan Kumar Sohpal
Published: (2020-09-01)

Seroprevalence of SARS-CoV-2 Infection Among People Living with HIV in Libreville, Gabon
by: Samira Zoa-Assoumou, et al.
Published: (2024-12-01)

The effect of SARS-CoV-2 Omicron BA. 5.2 infection on perioperative physiological indicators in orthopedic patients
by: Hao Wu, et al.
Published: (2025-01-01)

Idiopathic Multicentric Castleman Disease following SARS-CoV-2 Vaccination
by: Chien-Yu Ker, et al.
Published: (2023-07-01)

Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
by: Thomas E. Hickey, et al.
Published: (2025-01-01)

Reduced Presence of SARS-CoV-2 microRNA-like Small RNA in the Serum of Patients with Post-Acute Sequelae SARS-CoV-2 Infection
by: Maria Alfreda Stincarelli, et al.
Published: (2025-01-01)

Difference of SARS-CoV-2 infection and influence factors between people with and without HIV infection
by: Jianhui Yang, et al.
Published: (2025-01-01)

An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments
by: Ajit Ahlawat, et al.
Published: (2020-07-01)

Investigating SARS-CoV-2 Neutralising Antibody Response in Sheep
by: Milena Samojlović, et al.
Published: (2024-12-01)

Comprehensive Analysis of the Immune Response to SARS-CoV-2 Epitopes: Unveiling Potential Targets for Vaccine Development
by: Huixiong Deng, et al.
Published: (2025-01-01)

SARS-CoV-2 drug resistance and therapeutic approaches
by: Sania Batool, et al.
Published: (2025-01-01)

Recent advances in nutritional metabolism studies on SARS-CoV-2 infection
by: Yufen Jiang, et al.
Published: (2025-03-01)

CO2 levels and SARS-CoV-2 transmission in public schools: A retrospective cohort study in Montreal (Canada)
by: Olivier Séguin, et al.
Published: (2025-03-01)